Importantly, a recent study investigating the effects of STAT5a on breast cancer cell migration and invasion showed that prolactin (Prl)-induced activation of STAT5a inhibited migration and invasion of BT-20 and T-47D human breast cancer cells [10]. The gene discussed is STAT5A; the disease is breast cancer.